Serum sickness, encephalitis and other complications of anti-cytokine therapy
Keywords: ناتالیزوماب; anti-TNF therapy; infliximab; adalimumab; certolizumab pegol; natalizumab; safety; immunogenicity; progressive multifocal leucoencephalopathy